| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 32 |
| 1 | ASPIRIN 325 MG | 32 |
| 2 | ASPIRIN 81 MG | 32 |
| 3 | CLOPIDOGREL | 26 |
| 4 | ADALIMUMAB | 20 |
| 5 | CLOPIDOGREL BISULFATE | 17 |
| 6 | FUROSEMIDE | 15 |
| 7 | BISOPROLOL FUMARATE | 14 |
| 8 | DABIGATRAN ETEXILATE | 14 |
| 9 | RIVAROXABAN | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DOXAPRAM HYDROCHLORIDE | 1 | 0.0455 |
| 1 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 2 | MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM | 1 | 0.0154 |
| 3 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 4 | HEMIN | 1 | 0.0017 |
| 5 | ANDEXANET ALFA | 1 | 0.0014 |
| 6 | ROCURONIUM BROMIDE | 10 | 0.0008 |
| 7 | TENECTEPLASE | 1 | 0.0006 |
| 8 | MIRVETUXIMAB SORAVTANSINE | 1 | 0.0006 |
| 9 | TAMOXIFEN CITRATE | 3 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 38 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 33 |
| 2 | Factor Xa Inhibitor [EPC] | 25 |
| 3 | Benzodiazepine [EPC] | 19 |
| 4 | P2Y12 Platelet Inhibitor [EPC] | 19 |
| 5 | Corticosteroid [EPC] | 18 |
| 6 | Loop Diuretic [EPC] | 16 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 13 |
| 8 | Proton Pump Inhibitor [EPC] | 13 |
| 9 | General Anesthetic [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin [EPC] | 1 | 0.0003 |
| 1 | Antifibrinolytic Agent [EPC] | 3 | 0.0003 |
| 2 | General Anesthetic [EPC] | 11 | 0.0003 |
| 3 | Human Immunoglobulin G [EPC] | 5 | 0.0002 |
| 4 | Vitamin K [EPC] | 2 | 0.0002 |
| 5 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 6 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 7 | CD38-directed Cytolytic Antibody [EPC] | 1 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 19 | 0.0002 |